Sergei N. Orlov, Artem M. Tverskoi, Svetlana V. Sidorenko, 等. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?[J]. Genes & Diseases, 2021,8(3).
Sergei N. Orlov, Artem M. Tverskoi, Svetlana V. Sidorenko, et al. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?[J]. Genes & Diseases, 2021,8(3).
Sergei N. Orlov, Artem M. Tverskoi, Svetlana V. Sidorenko, 等. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?[J]. Genes & Diseases, 2021,8(3). DOI: 10.1016/j.gendis.2020.01.008.
Sergei N. Orlov, Artem M. Tverskoi, Svetlana V. Sidorenko, et al. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?[J]. Genes & Diseases, 2021,8(3). DOI: 10.1016/j.gendis.2020.01.008.
Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?
摘要
Abstract
With an exception of few reports
the plasma concentration of ouabain and marinobufagenin
mostly studied cardiotonic steroids (CTS) assessed by immunoassay techniques
is less than 1 nM. During the last 3 decades
the implication of these endogenous CTS in the pathogenesis of hypertension and other volume-expanded disorders is widely disputed. The threshold for inhibition by CTS of human and rodent α1-Na
K-ATPase is ∼1 and 1000 nM
respectively
that rules out the functioning of endogenous CTS (ECTS) as natriuretic hormones and regulators of cell adhesion
cell-to-cell communication
gene transcription and translation
which are mediated by dissipation of the transmembrane gradients of monovalent cations. In several types of cells ouabain and marinobufagenin at concentrations corresponding to its plasma level activate Na
K-ATPase
decrease the [Na
+
]
i
/[K
+
]
i
-ratio and increase cell proliferation. Possible physiological significance and mechanism of non-canonical Na